Thrombocytopenia after open heart surgery is common and may be associated with increased blood loss. During the use of pump oxygenators for cardiopulmonary bypass the whole of the patient's circulating blood volume is exposed to progressive mechanical trauma which produces changes in the factors affecting coagulation (Rothnie, Norman, Steele, and Kinmonth, 1960; Kendall and Lowenstein, 1962; Gans and Krivit, 1962; Gibbon and Camishion, 1964) , in particular a reduction in circulating platelets. Grindon and Schmidt (1969) perfused with platelet-poor blood wthout impairing coagulation, but, in our experience, the immediate post-perfusion thrombocytopenia has been the main cause of impaired coagulation. Low platelet counts of 70,000/mm3 (Couch, 1967) and 60,000/mm3 (Oberman, 1967) have been quoted, but, like Kahn, Strang, and Wilson (1968) , we regard levels below 50,000/mm3 as critical.
Exposing the whole circulating blood volume to mechanical trauma appeared undesirable. Blood was therefore withdrawn from the patient before bypass (Dodrill et al., 1957; Hardesty, Bayer, and Bahnson, 1968) . This autologous blood was later returned. Removal of blood from even the very ill patient was considered feasible as these patients had an increased blood volume due to congestive heart failure.
The purpose of this study was to evaluate the lCorrespond-nce to P.W.J., Dept. of Anaesthetics above technique by measuring the platelet levels and total blood loss after the perfusion. Heparin reduces circulating platelets in vivo (Kirby, 1958) and in vitro (Perkins, Osborn, and Gerbode, 1958) , but as acid citrate dextrose (ACD) is reported to increase platelet survival (Perkins et al., 1958) , the effect of using either heparin or ACD as the anticoagulant was also investigated.
METHOD
Two groups of patients operated on by two different surgical teams were investigated and compared with their respective control groups. The operations performed in these groups are listed in Table I .
The operations performed in both control groups were consecutive cases starting before this study. In both study groups patients were also consecutive. Patients who had known preoperative coagulation disorders and any patient who bled due to faulty surgical haemostasis were excluded from both control and study groups.
GROUP 1 (23 patients) From each patient 840 ml of blood was collected in two 540-ml transfusion bottles, each containing 120 ml of ACD anticoagulant. The blood was taken approximately 5 minutes before heparin was given for bypass, via a 100-cm tube of 4 mm internal diameter (ID) inserted in the right atrium and secured by a purse-string suture (Fig. 1 The collected blood from both groups of patients was stored at 40 C until required at the end of bypass. Patients in both study groups received no donor blood before bypass but, to compensate for the volume of blood withdrawn, a similar volume of ACD donor blood, sometimes up to five days old, was added to the pump oxygenator prime to maintain a safe operating volume within the Rygg oxygenator during bypass. The prime was buffered with sodium bicarbonate (25 mEq/litre). The volume of the priming fluid (5% dextrose in 0-18% normal saline) was calculated at 20 ml/kg body weight (Cooley, Beall, and Grondin, 1962) . All the perfusions were normothermic except in those cases involving surgery of the aortic valve in which hypothermia (32°C oesophageal) was used. When the bypass was completed, intravenous protamine sulphate was given to neutralize circulating heparin, the dose required having been determined by a heparin protamine titration (Perkins et al., 1956 ).
The autologous blood was then returned to the patient via a drip set connected to the arterial line of the pump oxygenator. This drip set was attached to the luer side arm of 12 mm ID polycarbonate connexion proximal to the arterial pump. The introduction of blood at this point of the circuit allowed the stored blood to be warmed and filtered before it entered the patient. The remaining autologous blood in the arterial line was displaced with blood from the oxygenator.
The infusion time varied from 5 to 15 minutes, being controlled by the central venous pressure (CVP) which was maintained below 20 cm H20. In group 1, calcium gluconate, 10 g per litre of blood, was given to cover the effect of citrate contained in the ACD autologous blood. In group 2, a further dose of protamine sulphate, 30 mg/litre, was later given to neutralize the heparin in the autologous blood. After all the autologous blood had been returned to the patient stored donor blood was given to replace overall blood loss (the age of this blood varied from two to five days).
Serial platelet counts according to the method of Lempert (1935) were made at the following times: (1) before operation; (2) at the end of bypass; (3) 10 minutes after autologous blood transfusion; (4) on return to the intensive care unit; (5) on the first postoperative day; and (6) on the second postoperative day.
All platelet counts were made as routine haematological procedures by an experienced technician who was unaware of the nature of the study.
Measurement of the total blood loss was measured in millilitres per square metre (ml/m2); this began immediately after giving the autologous blood and was maintained until all chest drains were removed, as described by Smith et al. (1964) . Re-exploration of two patients was performed, one from each study group, due to haemothorax. These patients' blood loss figures are included in Table III. The platelet counts and blood loss data for the study groups were compared with those for the respective control groups who received only donor ACD blood after bypass. These data were compared using Student's t test, accepting P<0 05 as a level of significance.
RESULTS
The mean platelet increases for both groups, due to autologous blood transfusion, are shown in Table II . In group 1, this improvement over the Table III . Blood loss in group 1 shows that the patient who received autologous ACD blood produced a significant reduction of 26-7% (P<0.05 one-tail Student's t test) as compared with the control figures. Blood loss in group 2 shows that after transfusion with heparinized autologous blood a reduction of 17.6% was produced, which One patient from each group was re-explored due to haemothorax.
was not significant (P>0 1, one-tail Student's t test) as compared with figures for blood loss in control patients in group 2.
DISCUSSION
This investigation was begun because we were concerned about the high blood loss often associated with platelet counts below 50,000/mm3.
The accepted treatment of postoperative haemorrhage associated with a low platelet count is by the transfusion of fresh blood (Oberman, 1967) or platelet concentrates (Woods, Taswell, Kirklin, and Owen, 1967) . As a method of reducing these demands on the transfusion service, autologous blood was used in a similar manner to that described by Hardesty et al. (1968) . In group 2 of our series, our results confirm their work using heparin as the anticoagulant. Our methods differed in that smaller volumes were collected and stored in glass bottles at 4' C to increase platelet survival (Goldstein, Bunker, and McGovern, 1964) . In group 1 of our series, when ACD autologous blood was used, the improvement in blood loss became significant (P<0 05).
We feel it is important not to return the autologous blood until after the protamine sulphate has neutralized the circulating heparin and is seen to be effective by the production of visible clots. This reduces the loss of the transfused autologous blood from the sites of haemorrhage. During the transfusion the CVP was increased but was not allowed to rise above 20 cm H20 to prevent circulatory overload.
In our study these methods for raising the platelet count did not produce as high an increase as that produced by the transfusion of platelet concentrates, described by Woods et al. (1967) , who extracted donor platelets from up to 8 units of blood collected on the morning of the operation. We feel that our method is as effective in reducing blood loss and has the virtue of simplicity and of supplying autologous platelets, and possibly other coagulation factors.
Figures 4 and 5 illustrate that the immediate increases in the mean platelet count in both study groups were maintained at a higher level than in the control groups up to the second postoperative day. It is interesting to note that in group 1 the mean platelet count 10 minutes after the autologous blood had been given was higher than after surgery was completed. After bypass and heparin reversal the utilization of platelets should be at its peak, and this may suggest that platelets stored in ACD blood are immediately more effective than those stored in heparin. The mean bypass time in study group 1 was reduced by 16 minutes and this was achieved without making any changes in surgical technique between the control and study groups. In this group the majority of operations were for mitral valve replacement and the reduced bypass time can probably be explained by increased experience. However, in study group 2, the reason for increased bypass time is that some operations for replacement of the mitral valve are accompanied by either aortic or tricuspid valve surgery.
The greater part of the decrease in platelets occurs within 15 minutes after bypass begins. Further but small reductions continue to occur until the platelet count becomes stabilized about 30 minutes after the start of bypass (Kendall and Lowenstein, 1962 ). Therefore we did not anticipate any improvement in the platelet count in study group 1 due to reducing the mean bypass time to 68 minutes as compared with the control group mean bypass time of 84 minutes.
On the other hand, prolonged bypass time is likely to affect other clotting factors and so may increase postoperative blood loss. The longer bypass times in study group 2 as compared with the control (Table II) could have biased the results and may explain the smaller reduction in blood loss after heparinized autologous blood in group 2 as compared with group 1 (Table III) .
In our study the use of autologous blood by these simple techniques has raised platelet counts from critical to acceptable post-bypass levels. At times it may not be possible to collect blood into ACD as in group 1, due, for example, to a low circulating blood volume or poor cardiac output. In these circumstances it may be preferable to use the method described for group 2.
